LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?
LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?
Objective: The clinical benefit of lowering LDL cholesterol (LDL-C) in secondary prevention is well known from clinical trials, especially in diabetic patients. The aim of this study was to evaluate LDL-C reduction in diabetic versus non-diabetic patients after percutaneous coronary intervention in clinical praxis.
Materials and methods: An observational...
Source: Radcliffe Cardiology - Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research
More News: Angioplasty | Cardiology | Cholesterol | Clinical Trials | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Percutaneous Coronary Intervention | Study